Regulation of Gene Expression Using dCas9-SunTag Platforms

  • Protocol
  • First Online:
Epigenomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2577))

Abstract

Regulating gene expression is important for basic research and therapeutic applications. The epigenome is a record of genetic modifications such as DNA methylation and histone modifications, and epigenetic changes can play a key role in modifying gene expression. With the advent of genome editing technologies, it has become possible to manipulate the epigenome of specific genomic regions to control gene expression. In particular, CRISPR–Cas9 systems have been used widely for epigenome editing due to their high efficiency, versatility, specificity, and ease of use. Here, we describe a protocol for the upregulation of specific genes using the dCas9-SunTag system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Timp W, Feinberg AP (2013) Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13:497–510

    Article  CAS  Google Scholar 

  2. Chatterjee A, Rodger EJ, Eccles MR (2017) Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol 51:149–159

    Article  Google Scholar 

  3. Mazzone R, Zwergel C, Artico M et al (2019) The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics 11:34

    Article  Google Scholar 

  4. Urdinguio RG, Sanchez-Mut JV, Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8:1056–1072

    Article  CAS  Google Scholar 

  5. Rosen ED, Kaestner KH, Natarajan R et al (2018) Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes 67:1923–1931

    Article  CAS  Google Scholar 

  6. Butler MG (2009) Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet 26:477–486

    Article  Google Scholar 

  7. Martella A, Fisher AI (2021) Elucidative role of CRISPR-based epigenetic modifiers and CRISPR-induced chromosome conformational changes. CRISPR J 4:1

    Article  Google Scholar 

  8. Maeder ML, Linder SJ, Cascio VM et al (2013) CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10:977–979

    Article  CAS  Google Scholar 

  9. Perez-Pinera P, Kocak DD, Vockley CM et al (2013) RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 10:973–976

    Article  CAS  Google Scholar 

  10. Mali P, Aach J, Stranges PB et al (2013) CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31:833–838

    Article  CAS  Google Scholar 

  11. Konermann S, Brigham MD, Trevino AE et al (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583–588

    Article  CAS  Google Scholar 

  12. Breunig CT, Köferle A, Neuner AM et al (2021) CRISPR tools for physiology and cell state changes: potential of transcriptional engineering and epigenome editing. Physiol Rev 101:177–211

    Article  CAS  Google Scholar 

  13. Morita S, Noguchi H, Horii T et al (2016) Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions. Nat Biotechnol 34:1060–1065

    Article  CAS  Google Scholar 

  14. Tanenbaum ME, Gilbert LA, Qi LS et al (1997) A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635–646

    Article  Google Scholar 

  15. Morita S, Horii T, Kimura M et al (2020) Synergistic upregulation of target genes by TET1 and VP64 in the dCas9-SunTag platform. Int J Mol Sci 21:1574

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by the Japan Agency for Medical Research and Development (AMED).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Izuho Hatada .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Morita, S., Horii, T., Hatada, I. (2023). Regulation of Gene Expression Using dCas9-SunTag Platforms. In: Hatada, I., Horii, T. (eds) Epigenomics. Methods in Molecular Biology, vol 2577. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2724-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2724-2_13

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2723-5

  • Online ISBN: 978-1-0716-2724-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Navigation